BLFS · ISSUER CIK 834365
BIOLIFE SOLUTIONS INC
Between Aug 1, 2026 and Oct 29, 2026, 11 BIOLIFE SOLUTIONS INC insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗11 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202621:59 | Oct 6, 2026 | BLFS | Chief Financial Officer | F · Tax | $38.61 | −95,933 | 183,248 | -34% | $3.7M | ||
| Oct 8, 202621:59 | Oct 6, 2026 | BLFS | Chief Financial Officer | D · To issuer | — | −256,000 | 0 | -100% | — | ||
| Oct 8, 202621:59 | Oct 6, 2026 | BLFS | Chief Financial Officer | A · Grant | — | +138,504 | 279,181 | +98% | — | ||
| Oct 8, 202621:59 | Oct 6, 2026 | BLFS | Director | D · To issuer | — | −53,156 | 0 | -100% | — | ||
| Oct 8, 202621:59 | Oct 6, 2026 | BLFS | Director | D · To issuer | — | −57,995 | 0 | -100% | — | ||
| Oct 8, 202621:59 | Oct 6, 2026 | BLFS | Director | D · To issuer | — | −26,857 | 0 | -100% | — | ||
| Oct 8, 202621:58 | Oct 6, 2026 | BLFS | Director | D · To issuer | — | −13,871 | 0 | -100% | — | ||
| Oct 8, 202621:58 | Oct 6, 2026 | BLFS | Chief Executive Officer, Director | F · Tax | $38.61 | −364,872 | 439,774 | -45% | $14.1M | ||
| Oct 8, 202621:58 | Oct 6, 2026 | BLFS | Chief Executive Officer, Director | D · To issuer | — | −826,454 | 0 | -100% | — | ||
| Oct 8, 202621:58 | Oct 6, 2026 | BLFS | Chief Executive Officer, Director | A · Grant | — | +463,130 | 804,646 | +136% | — | ||
| Oct 8, 202621:58 | Oct 6, 2026 | BLFS | Director | D · To issuer | — | −15,046 | 0 | -100% | — | ||
| Oct 8, 202621:57 | Oct 6, 2026 | BLFS | Director | D · To issuer | — | −44,943 | 0 | -100% | — | ||
| Oct 8, 202621:57 | Oct 6, 2026 | BLFS | EVP & Chief Scientific Officer | F · Tax | $38.61 | −70,000 | 314,058 | -18% | $2.7M | ||
| Oct 8, 202621:57 | Oct 6, 2026 | BLFS | EVP & Chief Scientific Officer | D · To issuer | — | −404,608 | 0 | -100% | — | ||
| Oct 8, 202621:57 | Oct 6, 2026 | BLFS | EVP & Chief Scientific Officer | A · Grant | — | +86,030 | 384,058 | +29% | — | ||
| Oct 8, 202621:55 | Oct 6, 2026 | BLFS | Chief Marketing Officer | F · Tax | $38.61 | −46,170 | 156,589 | -23% | $1.8M | ||
| Oct 8, 202621:55 | Oct 6, 2026 | BLFS | Chief Marketing Officer | D · To issuer | — | −194,786 | 0 | -100% | — | ||
| Oct 8, 202621:55 | Oct 6, 2026 | BLFS | Chief Marketing Officer | A · Grant | — | +78,390 | 202,759 | +63% | — | ||
| Oct 8, 202621:54 | Oct 6, 2026 | BLFS | Chief Technology Officer | F · Tax | $38.61 | −71,226 | 24,039 | -75% | $2.8M | ||
| Oct 8, 202621:54 | Oct 6, 2026 | BLFS | Chief Technology Officer | D · To issuer | — | −69,979 | 0 | -100% | — | ||
| Oct 8, 202621:54 | Oct 6, 2026 | BLFS | Chief Technology Officer | A · Grant | — | +94,070 | 95,265 | +7872% | — | ||
| Sep 22, 202617:11 | Sep 18, 2026 | BLFS | Chief Marketing Officer | F · Tax | $36.69 | −470 | 161,823 | -0% | $17K | ||
| Sep 22, 202617:11 | Sep 18, 2026 | BLFS | EVP & Chief Scientific Officer | F · Tax | $36.69 | −564 | 387,269 | -0% | $21K | ||
| Sep 22, 202617:11 | Sep 18, 2026 | BLFS | Chief Technology Officer | F · Tax | $36.69 | −421 | 47,135 | -1% | $15K | ||
| Sep 22, 202617:11 | Sep 18, 2026 | BLFS | President and CEO, Director | F · Tax | $36.69 | −2,775 | 728,196 | -0% | $102K | ||
| Sep 22, 202617:11 | Sep 18, 2026 | BLFS | Chief Financial Officer | F · Tax | $36.69 | −937 | 211,286 | -0% | $34K | ||
| Sep 10, 202616:50 | Sep 8, 2026 | BLFS | Chief Marketing Officer | F · Tax | $35.38 | −356 | 162,293 | -0% | $13K | ||
| Sep 10, 202616:50 | Sep 8, 2026 | BLFS | EVP & Chief Scientific Officer | F · Tax | $35.38 | −627 | 387,833 | -0% | $22K | ||
| Sep 10, 202616:50 | Sep 8, 2026 | BLFS | Chief Financial Officer | F · Tax | $35.38 | −1,026 | 212,223 | -0% | $36K |